On this page
Godrej Industries Q1 profit drops 19% as revenue climbs 22%; EBITDA margin expands
Our read
Godrej Industries is likely to shift investor focus from the Q1 profit decline to whether its sharply improved EBITDA margin can endure while the Creamline Dairy consolidation expands its consumer and agri platform.
For operators
Godrej Industries delivered strong Q1 operating momentum, with revenue up 22.2% and EBITDA margin expanding 220 bps to 11.1%, despite lower reported profit.
Watch
The gap between EBITDA growth and net-profit growth, especially interest expense, depreciation, tax rate and exceptional items.
The report,
Godrej Industries reported Q1 FY27 profit down 18.7% despite 22.2% revenue growth and stronger margins. Consumer-facing dairy, animal nutrition and vegetable oil businesses grew, while crop care declined; Agrovet further consolidated Creamline Dairy Products ownership.
One email each morning: the day’s top moves in Indian retail, why each matters and what to watch. Free. Stop any time.
Reported figures
From the report. Source details below
| Consolidated net profit fell 18.7% YoY to ₹284 crore from | ₹350 crore |
|---|---|
| Revenue rose 22.2% YoY to ₹5,448.1 crore from | ₹4,459.8 crore |
| EBITDA rose 52.4% YoY to ₹604.7 crore from | ₹397 crore |
| EBITDA margin widened to 11.1% from | 8.9% |
| Godrej Properties booking value rose 22% to | ₹8,651 crore |
What to watch next
- Whether EBITDA margin remains near or above 11% over the next two quarters.
- Creamline Dairy's revenue growth, milk procurement costs, EBITDA trajectory and integration disclosures after the stake increase.
- Input-cost trends in agricultural commodities, edible oils, animal feed, packaging and energy.
- Management guidance on FY27 margins, capex, leverage and consumer-demand conditions.
The counter-case
The case against this reading — not reported by the source.
The headline growth may overstate underlying earnings quality: revenue rose 22.2% and EBITDA increased 52.4%, yet consolidated net profit fell 18.7%, indicating that interest costs, depreciation, taxes, exceptional items, or losses/volatility in non-operating lines may be absorbing the operating improvement. The 220-basis-point margin expansion also needs testing for mix benefits, commodity-cycle effects, and one-off cost tailwinds rather than durable pricing power. Raising the Creamline Dairy stake to 99.78% could increase control, but it may also require further capital deployment and deepen exposure to dairy input-cost and execution risks.
The source
First seen